View in EDS PDF Full Text

A phase II evaluation of clofazimine plus doxorubicin in advanced, unresectable primary hepatocellular carcinoma.

Saved in:
Bibliographic Details
Title: A phase II evaluation of clofazimine plus doxorubicin in advanced, unresectable primary hepatocellular carcinoma.
Authors: Falkson CI; Department of Medical Oncology, University of Pretoria, Republic of South Africa. cfalkson@medic.up.ac.za, Falkson G
Source: Oncology [Oncology] 1999 Oct; Vol. 57 (3), pp. 232-5.
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
Journal Info: Publisher: Karger Country of Publication: Switzerland NLM ID: 0135054 Publication Model: Print Cited Medium: Print ISSN: 0030-2414 (Print) Linking ISSN: 00302414 NLM ISO Abbreviation: Oncology Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 10545792
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A phase II evaluation of clofazimine plus doxorubicin in advanced, unresectable primary hepatocellular carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Falkson+CI%22">Falkson CI</searchLink>; Department of Medical Oncology, University of Pretoria, Republic of South Africa. cfalkson@medic.up.ac.za<br /><searchLink fieldCode="AU" term="%22Falkson+G%22">Falkson G</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220135054%22">Oncology</searchLink> [Oncology] 1999 Oct; Vol. 57 (3), pp. 232-5.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Clinical Trial, Phase II; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Karger%22">Karger </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>0135054 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0030-2414 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200302414%22">00302414 </searchLink><i>NLM ISO Abbreviation: </i>Oncology <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=10545792
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1159/000012036
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 232
    Titles:
      – TitleFull: A phase II evaluation of clofazimine plus doxorubicin in advanced, unresectable primary hepatocellular carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Falkson CI
      – PersonEntity:
          Name:
            NameFull: Falkson G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 1999 Oct
              Type: published
              Y: 1999
          Identifiers:
            – Type: issn-print
              Value: 0030-2414
          Numbering:
            – Type: volume
              Value: 57
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Oncology
              Type: main
ResultId 1